BAFNA PHARMACEUTICALS
Back to Balance Sheet
|
BAFNA PHARMACEUTICALS Last 5 Year Contingent Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹18 Cr | ₹10 Cr | ₹6.17 Cr | ₹2.00 Cr | ₹5.00 Cr |
What is the latest Contingent Liabilities ratio of BAFNA PHARMACEUTICALS ?
Year | Contingent Liabilities |
---|---|
Mar2024 | ₹18 Cr |
Mar2023 | ₹10 Cr |
Mar2022 | ₹6.17 Cr |
Mar2021 | ₹2.00 Cr |
Mar2020 | ₹5.00 Cr |
How is Contingent Liabilities of BAFNA PHARMACEUTICALS Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹18 Cr | 67.43 | |
Mar2023 | ₹10 Cr | 69.85 | |
Mar2022 | ₹6.17 Cr | 208.45 | |
Mar2021 | ₹2.00 Cr | -60.00 | |
Mar2020 | ₹5.00 Cr | - |
Compare Contingent Liabilities of peers of BAFNA PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BAFNA PHARMACEUTICALS | ₹248.0 Cr | 10.3% | 18.9% | 32.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹375,100.0 Cr | -5.6% | -9.9% | -12.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹161,698.0 Cr | -2.5% | -8.4% | 21.7% | Stock Analytics | |
CIPLA | ₹128,239.0 Cr | -0.8% | 1.8% | -1.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,216.0 Cr | -2.4% | -4% | 4.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,855.0 Cr | -0.3% | -0.9% | -9.7% | Stock Analytics |
BAFNA PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BAFNA PHARMACEUTICALS | 10.3% |
18.9% |
32.1% |
SENSEX | -1.2% |
-1.2% |
-1.7% |
You may also like the below Video Courses